BREAST 2019 10.1016/j.breast.2019.06.005
Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer?
Cho1, WK; Choi, DH; Park, W; Kim, H; Cha, H

CANCER RES TREAT 2019 10.4143/crt.2018.423
Korean First Prospective Phase II Study, Feasibility of Prone Position in Postoperative Whole Breast Radiotherapy: A Dosimetric Comparison
Chung1, Y; Yu, JI; Park, W; Choi, DH

CANCER RES TREAT 2019 10.4143/crt.2018.575
Impact of Regions Nodal Irradiation or Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14)
Kim1, K; Jeong, Y; Shin, KH; Kim, JH; Ahn, SD; Kim, SS; Suh, CO; Kim, YB; Choi, DH; Park, W; Cha, J; Chun, M; Lee, DS; Lee, SY; Kim, JH; Park, HJ; Jung, W

CLIN BREAST CANCER 2019 10.1016/j.clbc.2019.04.003
The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08)
Choi1, N; Kim, K; Shin, KH; Kim, Y; Moon, HG; Park, W; Choi, DH; Kim, SS; Do Ahn, S; Kim, TH; Chun, M; Kim, YB; Kim, S; Choi, BO; Kim, JH

J CLIN MED 2019 10.3390/ijms20194943
Cyclin D1 is Associated with Radiosensitivity of Triple-Negative Breast Cancer Cells to Proton Beam Irradiation
Choi1, C; Park, S; Cho, WK; Choi, DH

TUMORI 2019 10.1177/0300891618792476
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy
Kim1, TG; Park, W; Kim, H; Choi, DH; Park, HC; Kim, SH; Cho, YB; Yun, SH; Kim, HC; Lee, WY; Lee, J; Kang, KM

J BREAST CANC 2019 10.4048/jbc.2019.22.e42
Gastric Complications after Adjuvant Radiotherapy for Breast Cancer
Cho1, WK; Choi, DH; Park, W; Kim, H; Kim, S; Shin, MH; Cha, H

BREAST J 2019 10.1111/tbj.13304
Heart-sparing radiotherapy with three-dimensional printing technology after mastectomy for patients with left breast cancer
Yang1, K; Park, W; Ju, SG; Chung, Y; Choi, DH; Cha, H; Park, JY; Shin, JS; Na, CH

CANCER RES TREAT 2019 10.4143/crt.2018.424
Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418)
Yoo1, GS; Park, W; Yu, JI; Choi, DH; Kim, YJ; Shin, KH; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, J

J BREAST CANC 2019 10.4048/jbc.2019.22.e25
The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
Cho1, WK; Park, W; Choi, DH; Kim, YB; Kim, JH; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ

BREAST 2019 10.1016/j.breast.2019.02.010
Is tumor bed boost necessary in patients who achieved ypCR following neoadjuvant chemotherapy and breast conserving therapy? (KROG 12-05 and 16-16)
Cho1, WK; Park, W; Choi, DH; Kim, YB; Su, CO; Shin, KH; Chie, EK; Kim, JH; Ahn, SD; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ; Shin, HS; Lee, HS; Lee, NK

J BREAST CANC 2019 10.4048/jbc.2019.22.e1
Central Nervous System Failure in Korean Breast Cancer Patients with HER2-Enriched Subtype: Korean Radiation Oncology Group 16-15 Multicenter Retrospective Study
Kim1, K; Shin, KH; Kim, JH; Choi, DH; Park, W; Kim, YB; Kim, HJ; Kim, JH; Park, H; Lee, SY; Kim, J; Oh, DH; Kim, IA

SURGERY 2019 10.1016/j.surg.2018.08.026
Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy
Huh1, JW; Kim, HC; Kim, SH; Park, YA; Cho, YB; Yun, SH; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK

BREAST 2019 10.1016/j.breast.2018.11.004
Adjuvant radiation therapy in small ductal carcinoma in situ
Cho1, WK; Choi, DH; Kim, H; Noh, JM; Park, W; Cha, H

CLIN BREAST CANCER 2019 10.1016/j.clbc.2018.08.009
Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16)
Cho1, WK; Park, W; Choi, DH; Kim, YB; kim, JH; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ

BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW

HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3
The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans
Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY

CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010
Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment
Cho1, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S

J GASTROINTEST SURG 2018 10.1007/s11605-018-3815-9
Prognostic Role of Carcinoembryonic Antigen Level after Preoperative Chemoradiotherapy in Patients with Rectal Cancer
Huh1, JW; Yun, SH; Kim, SH; Park, YA; Cho, YB; Kim, HC; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK

CANCER RES TREAT 2018 10.4143/crt.2017.575
Breast Conservation Therapy versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23
Kim1, K; Park, HJ; Shin, KH; Kim, JH; Choi, DH; Park, W; Ahn, SD; Kim, SS; Kim, DY; Kim, TH; Kim, JH; Kim, J